Studies on the antihistaminic effects of thymoquinone, thymohydroquinone and quercetin
Marozzi, F.J.; Kocialski, A.B.; Malone, M.H.
Arzneimittel-Forschung 20(10): 1574-1577
1970
ISSN/ISBN: 0004-4172 PMID: 4394727 Document Number: 24173
Document emailed within 1 workday
Related Documents
Zajac, A. 1977: Comparative pharmacological studies of N-(2-benzhydryloxyethyl)homomorpholine (linadryl H), linadryl and benadryl. I. Antihistaminic, anticholinergic and spasmolytic effects of linadryl H Acta Poloniae Pharmaceutica 34(3): 327-334Römer, D.; Weidmann, H. 1966: Pharmacological studies on the new antihistaminic Tavegil Die Medizinische Welt 51: 2791-2794
Badary, O.A.; Gamal El-Din, A.M. 2001: Inhibitory effects of thymoquinone against 20-methylcholanthrene-induced fibrosarcoma tumorigenesis Cancer Detection and Prevention 25(4): 362-368
Harpole, J.L.; Tucci, M.; Benghuzzi, H. 2015: Pathophysiological Effects of Thymoquinone and Epigallocatechin-3-Gallate on SK-OV-3 Ovarian Cancer like Cell Line Biomedical Sciences Instrumentation 51: 31-39
Safhi, M.Mohsin. 2016: Neuromodulatory Effects of Thymoquinone in Extenuating Oxidative Stress in Chlorpromazine Treated Rats Acta poloniae pharmaceutica 73(2): 529-535
Gerald, M.C.; Sethi, O.P.; Muhi-Eldeen, Z.; Mahishi, N.; Witiak, D.T. 1971: Pharmacological studies on the stereoselective antihistaminic and anticholinergic properties of L(S)- and D(R)-3-ethylamino-1-phenylpyrrolidine Archives Internationales de Pharmacodynamie et de Therapie 192(1): 78-87
Gutiérrez, B.; Dordal, A.; Fort, M.; Galicia, J.; Farré, A.J. 1996: Effects of E-4716, a new antihistaminic with antiallergic properties, on chemical mediators induction of immunologic reactions Methods and Findings in Experimental and Clinical Pharmacology 18(6): 397-406
Yao, F.; Zhang, R.; Fu, R.; He, W. 2011: Preventive and therapeutic effects of quercetin on hyperuricemia and renal injury in rats Wei Sheng Yan Jiu 40(2): 175-177
Asaum, J.; Matsuzaki, H.; Kawasak, S.; Kuroda, M.; Takeda, Y.; Kishi, K.; Hiraki, Y. 2000: Effects of quercetin on the cell growth and the intracellular accumulation and retention of adriamycin Anticancer Research 20(4): 2477-2483
Apisariyakul, A.; Chaichana, N.; Takemura, H. 1999: Dual effects of quercetin on contraction in cardiac and skeletal muscle preparations Research Communications in Molecular Pathology and Pharmacology 105(1-2): 129-138
Zhang, W.; Zhang, F. 2009: Effects of quercetin on proliferation, apoptosis, adhesion and migration, and invasion of Hela cells European Journal of Gynaecological Oncology 30(1): 60-64
Reiter, M.; Rupp, K.; Baumeister, P.; Zieger, S.; Harréus, U. 2009: Antioxidant effects of quercetin and coenzyme Q10 in mini organ cultures of human nasal mucosa cells Anticancer Research 29(1): 33-39
Wu, Z.-H.; Chen, Z.; Shen, Y.; Huang, L.-L.; Jiang, P. 2011: Anti-metastasis effect of thymoquinone on human pancreatic cancer Yao Xue Xue Bao 46(8): 910-914
Novotný, P. 1973: An antihistaminic with antidepressant action Casopis Lekaru Ceskych 112(41): 1276-1277
Randhawa, M.A.; Alghamdi, M.S.; Maulik, S.K. 2013: The effect of thymoquinone, an active component of Nigella sativa, on isoproterenol induced myocardial injury Pakistan Journal of Pharmaceutical Sciences 26(6): 1215-1219
Martin, T.Mitchell.; Benghuzzi, H.; Tucci, M. 2006: The effect of conventional and sustained delivery of thymoquinone and levodopa on SH-SY5Y human neuroblastoma cells Biomedical Sciences Instrumentation 42: 332-337
Norwood, A.A.; Tan, M.; May, M.; Tucci, M.; Benghuzzi, H. 2006: Comparison of potential chemotherapeutic agents, 5-fluoruracil, green tea, and thymoquinone on colon cancer cells Biomedical Sciences Instrumentation 42: 350-356
Alekhin, E.K.; Krasilova, I.L. 1998: The immunotropic activity of H1 antihistaminic preparations Eksperimental'naia i Klinicheskaia Farmakologiia 61(2): 79-86
Bindslev-Jensen, C.; Frølund, L.; Svendsen, U.G. 1989: Cetirizine. a new non-sedative antihistaminic agent Ugeskrift for Laeger 151(16): 1011-1012
Duchene-Marullaz, P.; Rispat, G.; Perriere, J.P. 1971: Several antihistaminic pharmacodynamic aspects, especially of Eprozinol Therapie 26(1): 155-162